Clinical Trial Update: Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether sleep improvement with trazodone can preserve or enhance cognition in individuals with amnestic mild cognitive impairm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Amnestic Mild Cognitive Impairment

Drugs mentioned

• Trazodone (trazodone)

Snippet

Sponsor: Johns Hopkins University | Conditions: AMCI - Amnestic Mild Cognitive Impairment, Sleep Disturbance | Phase 2 | Status: RECRUITING